SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

DiaMedica Therapeutics Inc. (DMAC)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
2.5 / 10
Letters
2
Latest Activity
Aug. 20, 2025
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Aug. 20, 2025 CORRESP Neutral/Informational Moderate DiaMedica Therapeutics Inc. has submitted a request for the acceleration of the effective date of its registration statement on Form S-3, which was filed on August 12, 2025. The c… Read Filing EDGAR
Aug. 18, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to DiaMedica Therapeutics Inc. that it will not review their registration statement filed on August 12, 2025. The letter emphasizes the company's responsi… Read Filing EDGAR
Aug. 6, 2025 CORRESP Neutral/Informational Moderate DiaMedica Therapeutics Inc. has submitted a request for the acceleration of the effective date for their registration statement on Form S-3, which was filed on August 1, 2025. The… Read Filing EDGAR
Aug. 5, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to DiaMedica Therapeutics Inc. that it will not review their registration statement filed on August 1, 2025. The letter emphasizes the company's responsib… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.